BrainCool AB (publ) is conducting a study with covid-19 patients
BrainCool AB, in collaboration with intensive care unit (ICU) clinics at Södersjukhuset (“SÖS”) in Stockholm Sweden, will conduct a small study (case series) in which covid-19 patients are to be treated for severe fever. Approximately 15 patients will be treated with the BrainCool™ System. SÖS has taken the initiative to carry out the study after promising results with the BrainCool™ System. The products have been successfully used to treat four covid-19 patients with severe and recurrent fever, where drugs have been shown to be ineffective in treating these fever peaks. In addition,